Evidence map›Paper›PMID 24348219›Full record

ArticleThe Yale journal of biology and medicine2013

How radiotherapy was historically used to treat pneumonia: could it be useful today?

Edward J Calabrese, Gaurav Dhawan

6 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in The Yale journal of biology and medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 97 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 3 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04380818 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19: Multi-central Prospective Study

TypeinterventionalSponsorGrupo de Investigación Clínica en Oncología RadioterapiaRan2020 to 2021Enrolled106ConditionsPneumonia, ViralArmsLow-dose radiotherapy, Hydroxychloroquine Sulfate, Ritonavir/lopinavir, Tocilizumab Injection [Actemra], Azithromycin
NCT04390412 phase1 / phase2unknown statusnot on this mapstarted 2020, after this paper: background citation

Assessment of Adding Low Dose Pulmonary Radiotherapy to the National Protocol of COVID-19 Management: A Pilot Trial

TypeinterventionalSponsorShahid Beheshti University of Medical SciencesRan2020 to 2020Enrolled5ConditionsCOVID, SARS (Severe Acute Respiratory Syndrome)ArmsLow Dose Radiotherapy
NCT04394182 nasuspendednot on this mapstarted 2020, after this paper: background citation

Low Doses of Lung Radiation Therapy in Cases of COVID-19 Pneumonia: Prospective Multicentric Study in Radiation Oncology Centers

TypeinterventionalSponsorFundacion GenesisCareRan2020 to 2022Enrolled15ConditionsPneumonia, Viral, Cytokine StormArmsUltra-Low-dose radiotherapy, ventilatory support with oxygen therapy, Lopinavir/ritonavir, Hydroxychloroquine, Azithromycin
NCT04394793 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Low Dose Radiation Therapy for Covid-19 Pneumonia: A Pilot Study

TypeinterventionalSponsorAll India Institute of Medical SciencesRan2020 to 2020Enrolled10ConditionsCOVID-19, PneumoniaArmsLow dose radiation therapy
NCT04427566 phase2terminatednot on this mapstarted 2020, after this paper: background citation

Vented COVID: A Phase II Study Of The Use Of Ultra Low-Dose Bilateral Whole Lung Radiation Therapy in the Treatment Of Critically Ill Patients With COVID-19 Respiratory Compromise

TypeinterventionalSponsorOhio State UniversityRan2020 to 2021Enrolled2ConditionsCOVID-19ArmsRadiation therapy
NCT04572412 nacompletednot on this mapstarted 2020, after this paper: background citation

Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia (a Phase I Feasibility Trial)

TypeinterventionalSponsorLancashire Teaching Hospitals NHS Foundation TrustRan2020 to 2022Enrolled2ConditionsCovid19ArmsLow dose Radiotherapy
3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 3 syntheses or guidelines pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2021
    Trial
  9. Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study.International journal of radiation oncology, biology, physics · 2021
    Trial
  10. COVID-19 pneumonia treated with ultra-low doses of radiotherapy (ULTRA-COVID study): a single institution report of two cases.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2021
    Trial
  11. Trial
  12. Article
  13. Review
  14. Review
  15. Article
  16. Radiotherapy for non-cancer diseases: benefits and long-term risks.International journal of radiation biology · 2024
    Review
  17. Article
  18. Review
  19. Review
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Edward J CalabreseDepartment of Public Health, Environmental Health Sciences, University of Massachusetts, Amherst, Massachusetts.
Gaurav DhawanDepartment of Public Health, Environmental Health Sciences, University of Massachusetts, Amherst, Massachusetts.
University of Massachusetts Amherst · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

X-ray therapy was used to treat pneumonia during the first half of the 20th century. Fifteen studies report that approximately 700 cases of bacterial (lobar and bronchopneumonia), sulfanilamide non-responsive, interstitial, and atypical pneumonia were effectively treated by low doses of X-rays, leading to disease resolution, based on clinical symptoms, objective disease biomarkers, and mortality incidence. The capacity of the X-ray treatment to reduce mortality was similar to serum therapy and sulfonamide treatment during the same time period. Studies with four experimental animal models (i.e., mice, guinea pig, cat, and dog) with bacterial and viral pneumonia supported the clinical findings. The mechanism by which the X-ray treatment acts upon pneumonia involves the induction of an anti-inflammatory phenotype that leads to a rapid reversal of clinical symptoms, facilitating disease resolution. The capacity of low doses of X-rays to suppress inflammatory responses is a significant new concept with widespread biomedical and therapeutic applications.

Indexed as

AnimalsCatsDisease Models, AnimalDogsDose-Response Relationship, RadiationGuinea PigsHumansLung Diseases, InterstitialMicePneumonia, BacterialPneumonia, ViralSulfonamidesSurvival AnalysisTreatment OutcomeX-Ray TherapySulfonamidesanti-inflammationhormesisinflammationpneumoniaradiotherapyX-rays

Identifiers

PMID24348219
PMCPMC3848110
OpenAlexW49375470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.